Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001778981-19-000001
Filing Date
2019-06-11
Accepted
2019-06-11 17:23:11
Documents
1
Period of Report
2019-06-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1446
  Complete submission text file 0001778981-19-000001.txt   2905
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EDESA BIOTECH INC. 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address
MacDonald Sean Arthur (Reporting) CIK: 0001778981 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37619 | Film No.: 19891819